Eli Lilly and Co (LLY) Holdings Cut by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky trimmed its holdings in shares of Eli Lilly and Co (NYSE:LLY) by 9.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 347,885 shares of the company’s stock after selling 36,636 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Eli Lilly and were worth $29,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in LLY. Pathstone Family Office LLC increased its position in shares of Eli Lilly and by 100.0% during the second quarter. Pathstone Family Office LLC now owns 58 shares of the company’s stock worth $4,774,000 after purchasing an additional 29 shares in the last quarter. Vantage Financial Partners Ltd. Inc. acquired a new stake in shares of Eli Lilly and during the second quarter worth about $494,000. Acrospire Investment Management LLC increased its position in shares of Eli Lilly and by 16.7% during the second quarter. Acrospire Investment Management LLC now owns 1,399 shares of the company’s stock worth $115,000 after purchasing an additional 200 shares in the last quarter. MPS Loria Financial Planners LLC acquired a new stake in shares of Eli Lilly and during the second quarter worth about $128,000. Finally, San Francisco Sentry Investment Group CA acquired a new stake in shares of Eli Lilly and during the second quarter worth about $129,000. 76.30% of the stock is owned by institutional investors.

Eli Lilly and Co (NYSE:LLY) opened at $85.07 on Monday. The stock has a market capitalization of $94,264.75, a PE ratio of 40.32, a P/E/G ratio of 1.77 and a beta of 0.35. Eli Lilly and Co has a 52-week low of $72.97 and a 52-week high of $89.09. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.38 and a quick ratio of 1.03.

Eli Lilly and (NYSE:LLY) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.05 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.03 by $0.02. The firm had revenue of $5.66 billion for the quarter, compared to analysts’ expectations of $5.52 billion. Eli Lilly and had a return on equity of 30.27% and a net margin of 9.90%. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.88 EPS. equities analysts expect that Eli Lilly and Co will post 4.22 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 9th. Investors of record on Thursday, February 15th will be given a $0.5625 dividend. This represents a $2.25 annualized dividend and a yield of 2.64%. The ex-dividend date of this dividend is Wednesday, February 14th. This is a boost from Eli Lilly and’s previous quarterly dividend of $0.52. Eli Lilly and’s payout ratio is 98.58%.

In other Eli Lilly and news, SVP Alfonso G. Zulueta sold 2,003 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $83.67, for a total transaction of $167,591.01. Following the transaction, the senior vice president now owns 43,580 shares in the company, valued at approximately $3,646,338.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Lilly Endowment Inc sold 195,000 shares of the business’s stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $85.14, for a total value of $16,602,300.00. Following the transaction, the insider now owns 123,513,247 shares in the company, valued at approximately $10,515,917,849.58. The disclosure for this sale can be found here. Insiders sold a total of 651,088 shares of company stock worth $56,439,586 in the last 90 days. 0.20% of the stock is currently owned by insiders.

A number of research firms have recently commented on LLY. BMO Capital Markets reiterated a “sell” rating and set a $71.00 target price on shares of Eli Lilly and in a research report on Thursday, September 28th. Cowen reiterated a “buy” rating and set a $95.00 target price on shares of Eli Lilly and in a research report on Wednesday, October 4th. Credit Suisse Group reiterated a “hold” rating on shares of Eli Lilly and in a research report on Wednesday, December 13th. Jefferies Group reiterated a “buy” rating and set a $89.00 target price on shares of Eli Lilly and in a research report on Thursday, August 31st. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $105.00 target price on shares of Eli Lilly and in a research report on Friday, October 13th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and nine have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $90.25.

WARNING: “Eli Lilly and Co (LLY) Holdings Cut by Teachers Retirement System of The State of Kentucky” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.com-unik.info/2017/12/25/eli-lilly-and-co-lly-holdings-cut-by-teachers-retirement-system-of-the-state-of-kentucky.html.

About Eli Lilly and

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Co (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly and (NYSE:LLY)

Receive News & Ratings for Eli Lilly and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly and and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit